(Q41758245)

English

A functional variant at miR-34a binding site in toll-like receptor 4 gene alters susceptibility to hepatocellular carcinoma in a Chinese Han population

scientific article published on 2 September 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

A functional variant at miR-34a binding site in toll-like receptor 4 gene alters susceptibility to hepatocellular carcinoma in a Chinese Han population (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

toll-like receptor

0 references

author name string

Zi-Cheng Jiang

1

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

Xian-Mei Tang

2

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

Ying-Ren Zhao

3

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

Lei Zheng

4

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

publication date

2 September 2014

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

35

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

12345-12352

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

https://scigraph.springernature.com/pub.10.1007/s13277-014-2547-z

0 references

Lack of association of two common polymorphisms rs2910164 and rs11614913 with susceptibility to hepatocellular carcinoma: a meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2547-Z

21 January 2018

Hepatocellular Carcinoma: Consensus Recommendations of the National Cancer Institute Clinical Trials Planning Meeting

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2547-Z

21 January 2018

The etiology of hepatocellular carcinoma and consequences for treatment

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2547-Z

21 January 2018

Hepatocellular carcinoma pathogenesis: from genes to environment

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2547-Z

21 January 2018

Liver pathology in obesity

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2547-Z

21 January 2018

Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2547-Z

21 January 2018

Cyclin D1 G870A polymorphism and the risk of hepatocellular carcinoma in a Chinese population.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2547-Z

21 January 2018

The TLR9 gene polymorphisms and the risk of cancer: evidence from a meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2547-Z

21 January 2018

Regulation of adaptive immunity by the innate immune system

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2547-Z

21 January 2018

Toll-like receptors and immune regulation: implications for cancer therapy

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2547-Z

21 January 2018

Toll-like receptors in the induction of the innate immune response

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2547-Z

21 January 2018

Association of polymorphisms in TLR genes and in genes of the Toll-like receptor signaling pathway with cancer risk

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2547-Z

21 January 2018

The miR-184 binding-site rs8126 T>C polymorphism in TNFAIP2 is associated with risk of gastric cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2547-Z

21 January 2018

Single nucleotide polymorphisms of Toll-like receptor 4 decrease the risk of development of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2547-Z

21 January 2018

Underexpression of miR-34a in hepatocellular carcinoma and its contribution towards enhancement of proliferating inhibitory effects of agents targeting c-MET

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2547-Z

21 January 2018

MicroRNA-125a-5p partly regulates the inflammatory response, lipid uptake, and ORP9 expression in oxLDL-stimulated monocyte/macrophages

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2547-Z

21 January 2018

Genetic variation in a microRNA-502 minding site in SET8 gene confers clinical outcome of non-small cell lung cancer in a Chinese population

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2547-Z

21 January 2018

MiR-196a binding-site SNP regulates RAP1A expression contributing to esophageal squamous cell carcinoma risk and metastasis.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2547-Z

21 January 2018

miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2547-Z

21 January 2018

Ectopic expression of miR-34a enhances radiosensitivity of non-small cell lung cancer cells, partly by suppressing the LyGDI signaling pathway

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2547-Z

21 January 2018

Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2547-Z

21 January 2018

Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2547-Z

21 January 2018

MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2547-Z

21 January 2018

miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2547-Z

21 January 2018

miR-221 overexpression contributes to liver tumorigenesis

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2547-Z

21 January 2018

Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2547-Z

21 January 2018

The MYCN oncogene is a direct target of miR-34a

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2547-Z

21 January 2018

p53 enters the microRNA world

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2547-Z

21 January 2018

Polymorphisms in Toll-like receptor genes and risk of cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2547-Z

21 January 2018

Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2547-Z

21 January 2018

The association between Toll-like receptor 4 (TLR4) polymorphisms and the risk of prostate cancer in Korean men.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2547-Z

21 January 2018

A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2547-Z

21 January 2018

Toll-like receptor 4 +3725 G/C polymorphism, Helicobacter pylori seropositivity, and the risk of gastric atrophy and gastric cancer in Japanese.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2547-Z

21 January 2018

Sequence Variants of Toll-Like Receptor 4 and Susceptibility to Prostate Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2547-Z

21 January 2018

DNMT3A -448A>G polymorphism and the risk for hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/25179842

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An update on the molecular genetics of hepatocellular carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25179842

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatocellular carcinoma--epidemiological trends and risk factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/25179842

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association study of single nucleotide polymorphisms in XRCC1 gene with risk of hepatocellular carcinoma in Chinese Han population

1 reference

https://pubmed.ncbi.nlm.nih.gov/25179842

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of MDR1 gene polymorphisms with the risk of hepatocellular carcinoma in the Chinese Han population

1 reference

https://pubmed.ncbi.nlm.nih.gov/25179842

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S13277-014-2547-Z

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41758245&oldid=1927332645"